ANALYSIS OF ESTROGEN DEFICIENCY ASSOCIATION WITH SALIVARY 25-HYDROXYVITAMIN D AND SALIVA FLOW RATE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

AIDA FADHILLA DARWIS; ARMIA SYAHPUTRA; SEFTY A. HARAHAP; PRASOJO SUJATMIKO; MUHAMMAD KEYVIN SYAH; CINDY C. SITORUS

doi:10.22159/ijap.2025.v17s4.05

Authors

AIDA FADHILLA DARWIS Department of Oral Medicine, Faculty of Dentistry, Universitas Sumatera Utara, Medan-20115 Indonesia https://orcid.org/0000-0002-1711-5651
ARMIA SYAHPUTRA Department of Periodontology, Faculty of Dentistry, Universitas Sumatera Utara, Medan-20115 Indonesia https://orcid.org/0000-0002-6474-897X
SEFTY A. HARAHAP Department of Dental Materials and Technology, Faculty of Dentistry, Universitas Sumatera Utara, Medan-20115 Indonesia
PRASOJO SUJATMIKO Orthopaedic Surgery Installation of Putri Hijau Hospital Sumatera Utara, Medan-20111, Indonesia
MUHAMMAD KEYVIN SYAH Undergraduate Student Faculty of Dentistry Universitas Sumatera Utara, Medan-20155, Indonesia
CINDY C. SITORUS Undergraduate Student Faculty of Dentistry Universitas Sumatera Utara, Medan-20155, Indonesia

DOI:

https://doi.org/10.22159/ijap.2025.v17s4.05

Keywords:

Estrogen, Salivary 25-hydroxyvitamin D, Salivary flow rates, Osteoporosis, Post-menopausal women

Abstract

Objective: This study analyzes the relationship between estrogen deficiency, salivary 25-hydroxyvitamin D, and salivary flow rates in postmenopausal women with osteoporosis.

Methods: A cross-sectional study involved 52 patients with Osteoporosis at Orthopaedic Installation Putri Hijau Hospital as subjects by purposive random sampling. The inclusion criteria were participants who had menopause for at least two years, did not take (vitamin D supplements, antihypertensives, antihistamines, antidepressants, replacement estrogen hormone therapy, experience parathyroid hormone disorders, Sjogren's Syndrome, diabetes, obesity, and/or currently undergoing cancer therapy. Excluded those who vomited or were unable to sit. Saliva samples were collected using the spitting method and estrogen and 25-hydroxyvitamin D levels were calculated using an ELISA kit, and saliva flow rate using a measuring glass. The data were analyzed using the Spearman correlation test.

Results: The mean value of salivary estrogen was 8 pg/ml, salivary 25-hydroxyvitamin D was 9.17 ng/dl, and salivary flow rate was 0.177 ml/minute. Based on the results of the Spearman correlation test between salivary estrogen and salivary 25-hydroxyvitamin D, it had a significant value (p<0.001) in the positive direction (r=0.925), and salivary estrogen and salivary flow rate had a significant value (p<0.001) in the positive direction (r=0.818).

Conclusion: there is a relationship between salivary estrogen and salivary 25-hydroxyvitamin D and salivary flow rate, with a positive correlation and significant value, meaning that the lower the salivary estrogen, the lower the salivary 25-hydroxyvitamin D and salivary flow rate.

References

1. Nurdiana N, Wulandari P, Amalia M. Improving life quality of postmenopausal women with oral health advancement. ABDIMAS. 2022;7(2):752-60. doi: 10.32734/abdimastalenta.v7i2.8328.

2. Jayusman PA, Nasruddin NS, Baharin B, Ibrahim NI, Ahmad Hairi H, Shuid AN. Overview on postmenopausal osteoporosis and periodontitis: the therapeutic potential of phytoestrogens against alveolar bone loss. Front Pharmacol. 2023;14:1120457. doi: 10.3389/fphar.2023.1120457, PMID 36909165.

3. Kementerian Kesehatan Republik Indonesia. Pedoman nasional pelayanan kedokteran Tatalaksana osteoporosis. Jakarta: Pusat data dan informasi Kementrian kesehatan RI; 2023. p. 1-12.

4. Santoro N, Roeca C, Peters BA, Neal Perry G. The menopause transition: signs symptoms and management options. J Clin Endocrinol Metab. 2021;106(1):1-15. doi: 10.1210/clinem/dgaa764, PMID 33095879.

5. Fernando R, Masulili SL, Lessang R, Kusdhany LS. Association between the degree of gingival inflammation and 25-hydroxyvitamin d status in postmenopausal women. Int J Appl Pharm. 2017;9(2):95-7.

6. John DS, Shenoy N. Vitamin D and periodontal health in postmenopausal women-an observational study. Rom J Diabetes Nutr Metab Dis. 2023;30(1):97-101.

7. Tabayyana QF, Pramesti HT, Tjahajawati S. Correlation between salivary pH in menopausal women and oral lactobacillus: a rapid review. J Int Dent Med Res. 2024;17(1):453-61.

8. Mishra R, Haider K, Rizwan R, Monga S, Pritam A, Singh P. Assessment of effect of menopause on saliva and oral health status. J Pharm Bioallied Sci. 2021 Nov 1;13(6)Suppl2:S1535-7. doi: 10.4103/jpbs.jpbs_276_21, PMID 35018024.

9. Imran M, Singh A, Bhardwaj A, Agrawal D. Prevalence of osteoporosis and associated risk factors among postmenopausal women: a cross-sectional study from Northern India. J Mid Life Health. 2022;13(3):206-12. doi: 10.4103/jmh.jmh_114_22, PMID 36950199.

10. Suganthan N, Kumanan T, Kesavan V, Aravinthan M, Rajeshkannan N. Vitamin D status among postmenopausal osteoporotic women: a hospital-based cross-sectional study from Northern Sri Lanka. BMC Nutr. 2020;6(1):15. doi: 10.1186/s40795-020-00341-y, PMID 32206326.

11. Amin U, McPartland A, O Sullivan M, Silke C. An overview of the management of osteoporosis in the aging female population. Womens Health (Lond). 2023;19:17455057231176655. doi: 10.1177/17455057231176655, PMID 37218715.

12. Al Obaidi NS, Qasim AA. Oral hygiene status in relation to salivary estradiol hormone level among pre-menopausal and post-menopausal Iraqi women. J Bagh Coll Dent. 2019;31(2):70-4. doi: 10.26477/jbcd.v31i2.2627.

13. Al Amiry AY, Najem AA. Salivary biomarkers (vitamin D, calcium, and estrogen hormone) in postmenopausal women with osteoporosis. J Indian Acad Oral Med Rad. 2023;35(1):41-4. doi: 10.4103/jiaomr.jiaomr_322_22.

14. Tjahajawati S, Rafisa A, Aldrin NV, Pramesti HT. Oral conditions salivary pH, flow rate phosphate level and phosphorus intake of pre- and postmenopausal women. Eur J Dent. 2025;19(4):979-84. doi: 10.1055/s-0044-1795076, PMID 39657940.

15. Divya Harika P, Garlapati K, Badam RK, Gone P, Aiman A, Rajani H. Taste changes and salivary flow rate disparities in premenopausal and postmenopausal women: exploring the zinc connection. Cureus. 2024 Jun 17;16(6):e62538. doi: 10.7759/cureus.62538, PMID 39022522.

16. Gupta A, Pallagatti S, Gupta D, Aggarwal A, Singh R. Unstimulated salivary estrogen in postmenopausal women with and without oral dryness: a prospective study. TODENTJ. 2022;16(1):1-8. doi: 10.2174/18742106-v16-e2202140.

17. Constantin V, Luchian I, Goriuc A, Budala DG, Bida FC, Cojocaru C. Salivary biomarkers identification: advances in standard and emerging technologies. Oral. 2025;5(2):1-19. doi: 10.3390/oral5020026.

18. Vaasanthi PA, Radha S, Nambisan B. Prevalence and determinants of osteoporosis in women aged 40-60 y. Int J Reprod Contracept Obstet Gynecol. 2016;5(12):4434-40. doi: 10.18203/2320-1770.ijrcog20164359.

19. Dieny FF, Fitranti DY. Faktor risiko osteoporosis pada wanita usia 40-80 tahun: status menopause dan obesitas. J Gizi Klin Indones. 2017;14(2):45-55. doi: 10.22146/ijcn.24872.

20. Rieder JK, Darabos K, Weierich MR. Estradiol and women’s health: considering the role of estradiol as a marker in behavioral medicine. Int J Behav Med. 2020;27(3):294-304. doi: 10.1007/s12529-019-09820-4, PMID 32006161.

21. Arsani NL, Purnamayanti NK, Purnomo KI, Wahyuni PD. Exploring estrogen hormon among perimenopause women and its impact on aging isues: a mixed method study. Bali Med J. 2024 Aug 1;13(3):1466-71. doi: 10.15562/bmj.v13i3.5486.

22. Soundarya B, Massillamani F, Kailasam S, Jayashree G, Narmadha N, Sornaa N. Salivary menopausal markers and oral health status a hidden hook up. J Mid Life Health. 2022;13(2):157-62. doi: 10.4103/jmh.jmh_61_21, PMID 36276617.

23. Lopez Baena MT, Perez Roncero GR, Perez Lopez FR, Mezones Holguin E, Chedraui P. Vitamin D menopause and aging: quo vadis? Climacteric. 2020;23(2):123-9. doi: 10.1080/13697137.2019.1682543, PMID 31736391.

24. Hassanein MM, Huri HZ, Baig K, Abduelkarem AR. Determinants and effects of vitamin D supplementation in postmenopausal women: a systematic review. Nutrients. 2023;15(3):685. doi: 10.3390/nu15030685, PMID 36771392.

25. Mei Z, Hu H, Zou Y, Li D. The role of vitamin D in menopausal women’s health. Front Physiol. 2023 Jun;14:1211896. doi: 10.3389/fphys.2023.1211896, PMID 37378077.

26. Wulandari P, Puspitadewi SR, Masulili SL, Auerkari EI, Iskandar HB, Baziad A. The profile of progesterone hormone vitamin D and bone density in postmenopausal women. J Int Dent Med Res. 2019;12(3):842-7.

27. Povaliaeva A, Zhukov A, Bogdanov V, Bondarenko A, Senko O, Kuznetsova A. Evaluation of the age-specific relationship between PTH and vitamin D metabolites. Bone Rep. 2024 Aug;22:101800. doi: 10.1016/j.bonr.2024.101800, PMID 39281298.

28. Poudel K, Poudel R, R Nair GK, Gaur A, Mohan V, Sharma KG. Evaluation of unstimulated salivary flow rate and oral symptoms in postmenopausal women a clinical study in healthy subjects. J Indian Acad Oral Med Radiol. 2023;35(2):202-6. doi: 10.4103/jiaomr.jiaomr_75_23.

29. Foglio Bonda A, Foglio Bonda PL, Bottini M, Pezzotti F, Migliario M. Chemical physical characteristics of artificial saliva substitutes: rheological evaluation. Eur Rev Med Pharmacol Sci. 2022;26(21):7833-9. doi: 10.26355/eurrev_202211_30132, PMID 36394731.

30. Kwon HK, Kim JM, Shin SC, Sung ES, Kim HS, Park GC. The mechanism of submandibular gland dysfunction after menopause may be associated with the ferroptosis. Aging. 2020;12(21):21376-90. doi: 10.18632/aging.103882, PMID 33159020.

31. Gill N, Ruparelia P, Verma O, Ruparelia K. Comparative evaluation of unstimulated whole salivary flow rate and oral symptoms in healthy premenopausal and postmenopausal women an observational study. J Indian Acad Oral Med Radiol. 2019;31(3):234-8. doi: 10.4103/jiaomr.jiaomr_104_19.

32. Ciesielska A, Kusiak A, Ossowska A, Grzybowska ME. Changes in the oral cavity in menopausal women a narrative review. Int J Environ Res Public Health. 2021;19(1):253. doi: 10.3390/ijerph19010253, PMID 35010513.

33. Guiglia R, Di Fede O, Lo Russo L, Sprini D, Rini GB, Campisi G. Osteoporosis jawbones and periodontal disease. Med Oral Patol Oral Cir Bucal. 2013;18(1):e93-9. doi: 10.4317/medoral.18298, PMID 23229255.

34. Ciesielska A, Kusiak A, Ossowska A, Grzybowska ME. Changes in the oral cavity in menopausal women a narrative review. Int J Environ Res Public Health. 2021;19(1):253. doi: 10.3390/ijerph19010253, PMID 35010513.

35. Sharma P. Biochemical alterations in postmenopausal women having osteoporotic risk. Asian J Pharm Clin Res. 2017;10(2):214-7. doi: 10.22159/ajpcr.2017.v10i2.15290.

36. Kumar PR, Joseph AK, Gokul G, Alex MP, Naveena G. Clinical outcome of calcium vitamin D3 and physiotherapy in osteoporotic population in the Nilgiris District. Int J Pharm Pharm Sci. 2016;8(3):157-60.

37. National Center for Biotechnology Information (NCBI). PubChem compound summary for CID 5280734, 25-hydroxyvitamin-D3; 2025. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/25-oh-vitamin-d3. [Last accessed on 22 May 2025].

38. National Center for Biotechnology Information (NCBI). PubChem compound summary for CID 5757, estradiol; 2025. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/5757. [Last accessed on 23 May 2025].